查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1195576

防粘连材料市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)

Adhesion Barrier Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预测期内，防粘连材料市场的复合年增长率预计为 7.9%。

在 COVID-19 大流行期间，外科医生实施并遵守了针对每个专业的严格指南，以便继续为患者提供安全有效的护理。对治疗产生了重大影响 例如，根据 BMJ 杂誌 2021 年 6 月发表的一篇文章，外科项目在大流行期间暂停了世界各地的各种非紧急或选择性外科手术。 这些变化对患者、提供者和医疗保健组织产生了相当大的影响。 因此，在 COVID-19 大流行期间外科手术的减少对 2020 年的市场增长产生了负面影响。 然而，推迟的手术在大流行后恢復，推动了市场增长。 随着大流行的消退，预计研究市场将在预测期内显着增长。 市场增长的具体驱动因素包括手术和运动相关伤害的增加，以及对粘连的医学影响的认识提高。

根据英国心臟基金会 2021 年 12 月发布的数据，2021 年 10 月英国估计完成了 32,938 例心臟手术，包括心臟手术。 粘连屏障是在手术后使用的，因此预计未来会有更多需要粘连屏障来减少疤痕的手术和手术。 因此，预计市场将在预测期内飙升。

此外，由于运动损伤和事故以及骨科手术导致的外科手术数量增加是推动粘连屏障市场的主要因素。 许多骨科疾病和其他慢性疾病表明必须进行手术。 根据美国国家安全委员会（NSC）公布的 2021 年美国数据，骑车受伤约占 375,797 人，运动受伤约占 409,224 人。 全地形车 (ATV)、轻便摩托车和小型自行车造成 238,404 人受伤，滑板、踏板车和气垫板造成 245,177 人受伤。 因此，预计受伤人数的增加将推动粘合剂屏障市场的全球增长。

发展中国家的医疗保健正在迅速变化。 随着这些国家人口的增加，对医疗设备的需求也会增加。 不断增加的疾病负担和创新的医疗方法占支出增长的近三分之二。 在预测期内，发展中国家的医疗保健支出预计会增加。 英国国家统计局 2022 年 5 月公布的数据显示，2021 年的医疗保健总支出估计为 2770 亿英镑（3734 亿美元），比上年增长 7.4%。 对医疗保健行业的具体投资可提供有吸引力的长期经济回报。 随着收入的增加，医疗保健是个人倾向于增加支出的一个领域。 因此，随着医疗成本的增加，手术粘合剂等先进产品的采用预计会增加。 因此，该研究涵盖的市场有望在研究预测期内实现增长。

因此，由于上述因素（例如手术和运动相关损伤的数量增加、医疗费用增加以及对粘连的医学影响的认识不断提高），研究中的市场预计会出现增长。 然而，外科手术的高成本加上□□与粘连屏障相关的副作用以及限制创新的严格法规预计将抑制粘□□连屏障市场的增长。

防粘连材料市场趋势

妇科手术行业有望增长

粘连病是术后患者发病的重要原因。 抗粘连屏障已被证明可以减少妇科手术中与粘连相关的并发症。 在开放手术中使用粘连屏障在预防粘连相关问题方面具有成本效益。

根据世卫组织 2021 年 6 月的最新消息，剖宫产在全球范围内继续增加，占分娩的五分之一 (21%) 以上。 此外，由于非传染性疾病和伤害的负担增加，一些国家的外科手术也在增加。 此外，根据美国疾控中心2022年7月公布的数据，2021年美国的剖宫产率将上升至32.1%。 剖腹产是一种需要使用粘连屏障的腹部手术。

此外，根据2021年8月发表在《妇产科学杂誌》上的一篇论文，妇科手术后的粘连形成很普遍，直接诱发并发症，给后续手术带来困难，所以问题很大。 防粘连屏障已被证明可以安全有效地解决这个问题。 与未经处理的对照相比，粘连屏障有助于显着降低粘连的范围和严重程度。

因此，由于上述因素，例如妇科手术的增加以及妇科手术中抗粘连材料的益处增加，预计该行业在预测期内将出现显着增长。

预计北美将占据较大的市场份额

该地区手术率的增加是有据可查的。 北美市场的增长受到技术进步、期望更高水平功能的老年患者以及激励复杂融合手术的报销模式的推动。 粘附屏障也可用于肿瘤手术。 此外，人们越来越意识到因受伤和慢性病问题而接受外科手术也推动了市场增长。

北美地区骨科手术数量的增加预计将对市场增长产生积极影响。 例如，根据美国骨科医师学会 2022 年 11 月发布的数据，2010 年美国估计进行了 2,550,232 例初次和翻修髋关节和膝关节置换术。 与上一年相比，累积程序技能增加了 14%。 由于骨科手术中使用了粘连屏障，因此髋关节和膝关节手术数量的增加有望推动市场增长。

此外，根据美国国家安全委员会 (NSC) 2021 年发布的数据，估计有 1170 万人因消费品受伤在美国急诊室接受治疗。 许多伤害涉及通常被认为安全的日常用品。 许多伤害发生在弱势群体，例如老人和幼儿。 根据加拿大健康信息研究所 2022 年 2 月的数据，剖腹产是 2021 年加拿大最常见的住院手术。 因此，预计防粘连屏障的采用将会增加。 因此，预计在预测期内，越来越多的需要医疗护理的伤害和越来越多的手术数量将进一步推动该地区的市场。

因此，上述所有因素（例如受伤病例的增加和骨科手术的增加）预计都将提振该地区的市场。

防粘连材料市场竞争者分析

防粘连材料市场竞争适中，由几家大型企业组成。 Anika Therapeutics、Baxter International、Leader Biomedical、Betatech Medical、FzioMed、Integra LifeSciences Holdings Corporation、强生和 MAST Biosurgery 等公司在抗粘连市场占有重要的市场份额。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 调查先决条件和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 手术和运动相关伤害的增加
    • 对粘连的医学影响的认识不断提高
  • 市场製约因素
    • 高昂的手术费用和与抗粘连屏障相关的副作用
    • 通过严格的监管限制技术创新
  • 行业吸引力 - 波特五力分析
    • 新进入者的威胁
    • 买家的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按产品分类
    • 合成粘合剂屏障
      • 透明质酸
      • 再生纤维素
      • 聚乙二醇
      • 其他合成粘合剂
    • 天然胶
      • 胶原蛋白
      • 纤维蛋白
  • 按剂型
    • 电影
    • 液体
    • 凝胶
  • 通过使用
    • 普通外科/腹部外科
    • 妇科
    • 心血管外科
    • 骨科
    • 神经外科
    • 其他用途
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Anika Therapeutics
    • Baxter International
    • Leader Biomedical
    • Betatech Medical
    • FzioMed
    • BIOSCOMPASS, INC.
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson
    • GUNZE LIMITED
    • Wuhan Sitaili Medical Apparatus Development Co.
    • TAICEND TECHNOLOGY CO., LTD
    • MAST Biosurgery

第7章 市场机会今后动向

简介目录
Product Code: 67614

The adhesion barrier market is expected to register a CAGR of 7.9% over the forecast period.

The pandemic had a significant impact on various surgical procedures initially, as there were strict guidelines specific to each specialty that was implemented and followed by surgeons to continue to provide safe and effective care to their patients during the COVID-19 pandemic. For instance, according to an article published by BMJ Journal in June 2021, surgical programs suspended various non-urgent or elective surgical procedures worldwide during the pandemic. These changes considerably impacted patients, providers, and healthcare organizations. Thus, reducing surgical procedures during the COVID-19 pandemic negatively impacted the market's growth in 2020. However, the postponed surgeries resumed during the post-pandemic period, which boosted the market's growth. As the pandemic has subsided, the studied market is expected to grow significantly over the forecast period. Specific factors driving the market growth include increased surgeries and sports-related injuries and rising awareness about the medical implications of adhesions.

According to the data published by British Heart Foundation in December 2021, an estimated 32,938 completed heart operations and other heart procedures were performed in England in October 2021. As adhesion barriers are used after surgeries, increasing operations and surgeries are expected to require adhesion barriers to reduce scars. Therefore, the market is expected to surge over the forecast period.

Moreover, a growing number of surgical procedures due to sports injuries, accidents, and orthopedic surgeries are primary factors driving the adhesion barrier market. There is a high prevalence of orthopedic diseases and other chronic conditions where surgery is suggested as mandatory. According to the data published by the National Safety Council (NSC) for the United States in 2021, bicycling accounted for about 375,797 injuries, and exercise accounted for about 409,224 injuries. The injuries due to an all-terrain vehicle (ATV), moped, and minibike were 238,404, and those due to skateboard, scooter, and hoverboard were 245,177. Therefore, an increasing number of injuries is expected to propel the growth of the adhesion barrier market globally.

Healthcare in developing countries is undergoing rapid changes. The growing population in these countries will likely lead to increased demand for medical devices. The growing burden of diseases and innovative medical treatments contributed to nearly two-thirds of the rise in spending. Spending on healthcare in developing countries is expected to increase during the forecast period. According to the data published by the Office for National Statistics of the United Kingdom in May 2022, the estimated total healthcare expenditure in 2021 was GBP 277 billion (USD 373.4 billion), which increased by 7.4% when compared to the spending in the last year. Specific investments in the healthcare sector offer attractive long-term financial benefits. Medical care is one area where individuals tend to increase spending as incomes grow. Hence, with the increasing healthcare expenditure, the adoption of advanced products, such as adhesion barriers for surgeries, is expected to increase. Thus the studied market is expected to experience growth during the forecast period of the study.

Therefore, due to the aforementioned factors, such as the increased volume of surgeries and sports-related injuries, increasing healthcare expenditure, and rising awareness about the medical implications of adhesions, the studied market is expected to experience growth. However, the high cost of surgical procedures coupled with side effects associated with adhesion barriers and stringent regulations resulting in limited technological innovations are expected to restrain the growth of the adhesion barrier market.

Adhesion Barrier Market Trends

Gynecological Surgeries Segment Expected to Witness Growth

The adhesive disease represents a significant cause of morbidity for postoperative patients. Adhesion barriers have been proven to reduce adhesion-related complications in gynecological surgery. The use of adhesion barriers in open surgery is cost-effective in preventing adhesion-related problems.

According to the WHO updates from June 2021, cesarean section procedures are continuously rising globally, accounting for more than 1 in 5 (21%) childbirths. Moreover, several countries are also experiencing a rise in surgical procedures owing to the rising burden of non-communicable diseases and injuries. Furthermore, per the data published by CDC in July 2022, the cesarean delivery rate increased to 32.1% in the United States in 2021. Cesarean delivery is an abdominal surgery that requires the use of adhesion barriers.

Furthermore, according to an article published by the Journal of Obstetrics and Gynaecology in August 2021, adhesion formation after gynaecologic surgeries is widespread and highly problematic as it directly induces complications and makes subsequent surgeries more difficult. Adhesion barriers to overcoming this problem have proven safe and effective. Adhesion barriers help in significantly reducing both adhesion extent and severity in comparison to untreated control.

Thus, the segment is expected to witness significant growth over the forecast period due to the above-mentioned factors, such as increasing gynecological surgeries and increasing advantages of adhesion barriers in gynecological surgeries.

North America Anticipated to Hold a Significant Market Share

The increasing rate of surgery in the region has been well-documented. Market growth in North America is driven by technological advancement, elderly patients expecting higher levels of function, and reimbursement models incentivizing complex fusion surgery. Adhesion barriers are also valuable for oncology surgeries. Furthermore, growing awareness among the population to approach surgical procedures in case of injuries and chronic disease problems is also driving market growth.

The rising number of orthopedic procedures within the North American region will likely positively impact market growth. For instance, according to the data published by the American Academy of Orthopedic Surgeons in November 2022, an estimated 2,550,232 primary and revision hip and knee arthroplasty procedures were performed in the decade in the United States. It showed a cumulative procedural volume growth of 14% compared to the previous year. As adhesion barriers are used for orthopedic procedures, the increasing number of hip and knee arthroplasty procedures is expected to enhance the market growth.

Additionally, according to the data published by National Safety Council (NSC) in 2021, an estimated 11.7 million people were treated in emergency departments of the United States for injuries resulting from consumer products. Most injuries involve everyday products that are often assumed to be safe. Many injuries occur to vulnerable populations such as older adults and young children. According to the Canadian Institute of Health Information data in February 2022, the most common inpatient surgery in Canada in 2021 was a cesarean section (C-section). This is expected to increase the adoption of adhesion barriers. Thus, the increasing number of injuries that require medical attention and a growing number of surgeries is further expected to boost the market in the region over the forecast period.

Thus, all the aforementioned factors, such as the rise in injury cases and the rising number of orthopedic surgeries, are expected to boost the market in the region.

Adhesion Barrier Market Competitor Analysis

The adhesion barrier market is moderately competitive and consists of several major players. Companies such as Anika Therapeutics, Baxter International, Leader Biomedical, Betatech Medical, FzioMed, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and MAST Biosurgery, among others, hold a substantial market share in the adhesion barrier market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in the Volume of Surgeries and Sports-related Injuries
    • 4.2.2 Rising Awareness about the Medical Implications of Adhesions
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Surgical Procedures Coupled with Side Effects Associated with Adhesion Barriers
    • 4.3.2 Stringent Regulations Resulting in Limited Technological Innovations
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Synthetic Adhesion Barriers
      • 5.1.1.1 Hyaluronic Acid
      • 5.1.1.2 Regenerated Cellulose
      • 5.1.1.3 Polyethylene Glycol
      • 5.1.1.4 Other Synthetic Adhesion Barriers
    • 5.1.2 Natural Adhesion Barriers
      • 5.1.2.1 Collagen
      • 5.1.2.2 Fibrin
  • 5.2 By Formulation
    • 5.2.1 Film
    • 5.2.2 Liquid
    • 5.2.3 Gel
  • 5.3 By Application
    • 5.3.1 General/Abdominal Surgeries
    • 5.3.2 Gynecological Surgeries
    • 5.3.3 Cardiovascular Surgeries
    • 5.3.4 Orthopedic Surgeries
    • 5.3.5 Neurological Surgeries
    • 5.3.6 Other Applications
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Anika Therapeutics
    • 6.1.2 Baxter International
    • 6.1.3 Leader Biomedical
    • 6.1.4 Betatech Medical
    • 6.1.5 FzioMed
    • 6.1.6 BIOSCOMPASS, INC.
    • 6.1.7 Integra LifeSciences Holdings Corporation
    • 6.1.8 Johnson & Johnson
    • 6.1.9 GUNZE LIMITED
    • 6.1.10 Wuhan Sitaili Medical Apparatus Development Co.
    • 6.1.11 TAICEND TECHNOLOGY CO., LTD
    • 6.1.12 MAST Biosurgery

7 MARKET OPPORTUNITIES AND FUTURE TRENDS